The different autophagy degradation pathways and neurodegeneration A Fleming, M Bourdenx, M Fujimaki, C Karabiyik, GJ Krause, A Lopez, ... Neuron 110 (6), 935-966, 2022 | 300 | 2022 |
Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease S Saiki, T Hatano, M Fujimaki, KI Ishikawa, A Mori, Y Oji, A Okuzumi, ... Scientific reports 7 (1), 7328, 2017 | 139 | 2017 |
A metabolic profile of polyamines in parkinson disease: A promising biomarker S Saiki, Y Sasazawa, M Fujimaki, K Kamagata, N Kaga, H Taka, Y Li, ... Annals of neurology 86 (2), 251-263, 2019 | 107 | 2019 |
Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease M Fujimaki, S Saiki, Y Li, N Kaga, H Taka, T Hatano, KI Ishikawa, Y Oji, ... Neurology 90 (5), e404-e411, 2018 | 105 | 2018 |
Iron supply via NCOA4-mediated ferritin degradation maintains mitochondrial functions M Fujimaki, N Furuya, S Saiki, T Amo, Y Imamichi, N Hattori Molecular and Cellular Biology 39 (14), e00010-19, 2019 | 73 | 2019 |
Neuroprotective effects of memantine via enhancement of autophagy K Hirano, M Fujimaki, Y Sasazawa, A Yamaguchi, KI Ishikawa, ... Biochemical and biophysical research communications 518 (1), 161-170, 2019 | 56 | 2019 |
Metabolomics‐based identification of metabolic alterations in PARK2 A Okuzumi, T Hatano, SI Ueno, T Ogawa, S Saiki, A Mori, T Koinuma, ... Annals of Clinical and Translational Neurology 6 (3), 525-536, 2019 | 52 | 2019 |
Mendelian neurodegenerative disease genes involved in autophagy E Stamatakou, L Wróbel, SM Hill, C Puri, SM Son, M Fujimaki, Y Zhu, ... Cell discovery 6 (1), 24, 2020 | 45 | 2020 |
Huntingtin-lowering strategies for Huntington’s disease RA Barker, M Fujimaki, P Rogers, DC Rubinsztein Expert opinion on investigational drugs 29 (10), 1125-1132, 2020 | 34 | 2020 |
Non-invasive diagnostic tool for Parkinson’s disease by sebum RNA profile with machine learning Y Uehara, SI Ueno, H Amano-Takeshige, S Suzuki, Y Imamichi, ... Scientific reports 11 (1), 18550, 2021 | 26 | 2021 |
Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease SI Ueno, T Hatano, A Okuzumi, S Saiki, Y Oji, A Mori, T Koinuma, ... Annals of Clinical and Translational Neurology 7 (3), 307-317, 2020 | 26 | 2020 |
Acute psychosis as an initial manifestation of hypothyroidism: a case report S Ueno, S Tsuboi, M Fujimaki, H Eguchi, Y Machida, N Hattori, H Miwa Journal of Medical Case Reports 9, 1-3, 2015 | 26 | 2015 |
Shared metabolic profile of caffeine in Parkinsonian disorders H Takeshige‐Amano, S Saiki, M Fujimaki, SI Ueno, Y Li, T Hatano, ... Movement Disorders 35 (8), 1438-1447, 2020 | 19 | 2020 |
Demyelinating peripheral neuropathy due to renal cell carcinoma K Nishioka, M Fujimaki, K Kanai, Y Ishiguro, T Nakazato, R Tanaka, ... Internal Medicine 56 (1), 101-104, 2017 | 12 | 2017 |
Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy A Mori, KI Ishikawa, S Saiki, T Hatano, Y Oji, A Okuzumi, M Fujimaki, ... PLoS One 14 (9), e0223113, 2019 | 11 | 2019 |
Zonisamide administration improves fatty acid β-oxidation in Parkinson’s disease SI Ueno, S Saiki, M Fujimaki, H Takeshige-Amano, T Hatano, G Oyama, ... Cells 8 (1), 14, 2018 | 11 | 2018 |
Immunocytochemical monitoring of PINK1/Parkin-mediated mitophagy in cultured cells M Fujimaki, S Saiki, Y Sasazawa, KI Ishikawa, Y Imamichi, K Sumiyoshi, ... Mitophagy: Methods and Protocols, 19-27, 2018 | 10 | 2018 |
Lymphomatoid granulomatosis with central nervous system involvement successfully treated with cyclophosphamide, high‐dose Cytarabine, dexamethasone, Etoposide, and rituximab … M Fujimaki, S Kawajiri, K Ichikawa, Y Tomizawa, T Nakazato, K Noda, ... CNS Neuroscience & Therapeutics 21 (7), 610, 2015 | 10 | 2015 |
Systemic metabolic alteration dependent on the thyroid‐liver axis in early PD K Miyamoto, S Saiki, H Matsumoto, A Suzuki, Y Yamashita, T Iseki, ... Annals of Neurology 93 (2), 303-316, 2023 | 9 | 2023 |
Loss of WIPI4 in neurodegeneration causes autophagy-independent ferroptosis Y Zhu, M Fujimaki, L Snape, A Lopez, A Fleming, DC Rubinsztein Nature Cell Biology 26 (4), 542-551, 2024 | 8 | 2024 |